BMS Partners with Cellares for Automated CAR-T Cell Therapy Production
Pharmaceutical giant Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into an agreement with cell therapy...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity